GBS FOUNDATION–KENYA

Our Medical Advisory Board

Clinical expertise supporting our commitment to better awareness, patient support, access to treatment and stronger health-system responses for people affected by GBS, CIDP and associated neuropathies.

Clinical Expertise. Patient-Centred Care.

The GBS Foundation–Kenya Medical Advisory Board brings together medical expertise to support the Foundation's work and strengthen understanding and responses to Guillain-Barré Syndrome, CIDP and associated neuropathies.

The Board provides an important link between patient experience, clinical knowledge and the wider healthcare system, helping to inform the Foundation's programmes, advocacy and engagement with healthcare stakeholders.

Our Commitment Better outcomes begin with knowing, understanding and responding to these conditions.

Meet Our Medical Advisory Board

Medical Advisory Board

Dr. Duncan Chengo

Duncan Chengo is a senior healthcare executive and a specialist in neuro-rehabilitation. He is the founder and CEO of Ability Clinics.
He serves as the Africa representative for the ADAPT's CII programs. This Pacific Asia caucus advocates for inclusive education. In partnership with ADAPT, Chengo leads the School Next Door project in Kenya. This initiative builds sustainable inclusive education systems for children with disabilities within the regular CBC curriculum.
Chengo is a senior lecturer at the Kenya Medical Training College and the Presbyterian University of East Africa. He is also a board member of the National Council for Persons with Disabilities (NCPWD), focusing on policy reforms and stakeholder collaboration.
As a Rotarian, he is the Director of Fundraising for the Rotary Club of Nairobi NABO.

Photo coming soon

Medical Advisory Board

Dr. John Doe

Neurologist

KNOW IT! NAME IT! FIGHT IT!

Strengthening Care Through Collaboration

Through collaboration between patients, healthcare professionals, researchers, institutions and other stakeholders, we can build a stronger care ecosystem for people affected by GBS, CIDP and associated neuropathies in Kenya.